Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer.

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast... To determine whether obesity is an independent prognostic factor among women receiving adjuvant chemotherapy for lymph node-positive breast cancer and to determine how obesity relates to other commonly used prognostic indicators. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of internal medicine Pubmed

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer.

Annals of internal medicine , Volume 120 (1): 8 – Jan 3, 1994

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer.


Abstract

To determine whether obesity is an independent prognostic factor among women receiving adjuvant chemotherapy for lymph node-positive breast cancer and to determine how obesity relates to other commonly used prognostic indicators.

Loading next page...
 
/lp/pubmed/obesity-as-an-adverse-prognostic-factor-for-patients-receiving-4ip0XWqtLu

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0003-4819
DOI
10.7326/0003-4819-120-1-199401010-00004
pmid
8250452

Abstract

To determine whether obesity is an independent prognostic factor among women receiving adjuvant chemotherapy for lymph node-positive breast cancer and to determine how obesity relates to other commonly used prognostic indicators.

Journal

Annals of internal medicinePubmed

Published: Jan 3, 1994

There are no references for this article.